Trump diagnosed with vein condition causing leg swelling: White House
White House spokesperson Karoline Leavitt, reading a letter from Trump's doctor at a press briefing, said both ailments were benign. His leg swelling is from a 'common' vein condition, and his hand is bruised from shaking so many hands, she told reporters.
The disclosure sought to put to rest a raft of Internet rumours that the 79-year-old Trump might be suffering from a serious ailment based on the photographic evidence.
After Leavitt's briefing, the White House released the letter from a US Navy officer who is Trump's physician, Sean Barbabella. It said Trump underwent a suite of tests about the issues.
Barbabella said an ultrasound on the president's legs 'revealed chronic venous insufficiency, a benign and common condition, particularly in individuals over the age of 70'.
The letter said there was no evidence that Trump had contracted deep vein thrombosis or arterial disease.
BT in your inbox
Start and end each day with the latest news stories and analyses delivered straight to your inbox.
Sign Up
Sign Up
Additional exams identified no signs of heart failure, kidney impairment, or a systemic illness, Barbabella said.
Leavitt told reporters Trump was not experiencing discomfort due to the condition.
Barbabella also said that Trump had bruising on the back of his right hand.
He described this as 'consistent with minor soft tissue irritation from frequent handshaking and the use of aspirin, which is taken as part of a standard cardiovascular prevention regimen'.
'President Trump remains in excellent health,' he said.
Kwame Amankwah, a physician who is chief of vascular surgery at the University of Connecticut in Hartford, said chronic venous insufficiency is usually an issue with the lower legs in which the veins have problems sending blood from the legs back to the heart.
It is usually treated with compression stockings and leg elevation, he said.
'Even if he doesn't have heart disease, the condition needs to be addressed. If it's not managed with compression stockings and elevation, severe swelling and ulcers can develop, warranting more significant medical interventions,' Amankwah said.
Todd Berland, a physician who is director of outpatient vascular interventions at NYU Langone Health, said chronic venous insufficiency 'has no overall effect on life expectancy. It's a quality-of-life issue, not a quantity of life issue'.
Trump underwent an extensive physical examination on Apr 11 at Walter Reed National Military Medical Center in suburban Washington. It said Trump had a normal heart rhythm and no major health problems. REUTERS

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles

Straits Times
16 hours ago
- Straits Times
Forum: Show the young they're not alone as they battle vaping
I refer to recent articles in The Straits Times highlighting the vaping crisis. What began as a trendy alternative to smoking among the young is now becoming a public health crisis with potentially severe social consequences. Vapes are now being laced with substances such as etomidate, further endangering the health of our youth and leading them towards a lifetime of addiction. As an organisation that strives to uplift youth, Allkin Singapore echoes these concerns. Through our work, we have seen how youth have adopted a permissive attitude towards vaping, as they often use it as a coping mechanism to manage negative emotions such as stress and boredom. We have encountered youth with no history of smoking who began vaping and are now at risk of substance addiction. However, as the ST articles rightly noted, enforcement alone is not enough. While it is critical to deter illegal distribution and use, we must also ask: What drives a young person to pick up a vape in the first place? And more importantly, who is walking alongside them as they try to put it down? Many avoid seeking help from their schools, for fear of being punished or charged. That's why supportive, non-judgmental interventions are key. From our experiences working with youth on smoking cessation, we found that engaging in group-based activities and one-to-one counselling were effective in enabling them to manage their behaviours. Our approach is rooted in the belief that young people don't just need to be stopped; they also need to be supported. They need safe spaces to talk about what they are going through – about stress, anxiety and identity. They need adults who will listen without judgment and offer empathy and guidance. Top stories Swipe. Select. Stay informed. World Trump says US will charge 19% tariff on goods from Philippines, down from 20% Singapore Two found dead after fire in Toa Payoh flat Singapore Singaporeans continue to hold world's most powerful passport in latest ranking Singapore Singaporeans aged 21 to 59 can claim $600 SG60 vouchers from July 22 Singapore Singapore, Vietnam agree to step up defence ties, dialogue between leaders Life Ozzy Osbourne, Black Sabbath's bat-biting frontman turned reality TV star, dies aged 76 Asia Malaysia govt's reform pledge tested as DAP chief bows over unresolved 2009 death of political aide Singapore Ports and planes: The 2 Singapore firms helping to keep the world moving As a society, we must respond to the vaping crisis not only with punitive measures but also with compassion, upstream prevention and community-based interventions. Helping youth take that first brave step away from vaping begins with showing them that they are not alone. Moagana Rani Head of Youth Service Allkin Singapore

Straits Times
a day ago
- Straits Times
The eye-opening science of close encounters with polar bears
Eight scientists working from the Norwegian icebreaker Kronprins Haakon are experimenting with new methods to monitor polar bears. LONGYEARBYEN - It's a pretty risky business trying to take a blood sample from a polar bear – one of the most dangerous predators on the planet – on an Arctic ice floe. First you have to find it and then shoot it with a sedative dart from a helicopter before a vet dares approach on foot to put a GPS collar around its neck. Then the blood has to be taken and a delicate incision made into a layer of fat before it wakes. All this with a wind chill of up to minus 30 deg C. For the last four decades, experts from the Norwegian Polar Institute (NPI) have been keeping tabs on the health and movement of polar bears in the Svalbard archipelago, halfway between Norway and the North Pole. Like the rest of the Arctic, global warming has been happening there three to four times faster than elsewhere. But this year, the eight scientists working from the Norwegian icebreaker Kronprins Haakon are experimenting with new methods to monitor the world's largest land carnivore, including for the first time tracking the PFAS 'forever chemicals' from the other ends of the Earth that finish up in their bodies. Top stories Swipe. Select. Stay informed. World Trump 'caught off guard' by Israel's strikes in Syria Opinion Singapore's vaping crisis lays bare the drug addiction nightmare for parents Singapore LTA seeks tailored solutions to improve Bukit Panjang LRT's maintenance inspections World US not rushing trade deals ahead of August deadline, will talk with China, Bessent says Multimedia 'It's very sad': She comforts loved ones turned away by inmates Opinion Sumiko at 61: 7 facts about facial skin ageing, and skincare ingredients that actually work Singapore Subsidies and grants for some 20,000 people miscalculated due to processing issue: MOH Opinion With Shatec cutting back operations, what's next for Singapore's hospitality sector? An AFP photographer joined them on this year's eye-opening expedition. Delicate surgery on the ice With one foot on the helicopter's landing skid, vet Rolf Arne Olberg put his rifle to his shoulder as a polar bear ran as the aircraft approached. Hit by the dart, the animal slumped gently on its side into a snowdrift, with Dr Olberg checking with his binoculars to make sure he had hit a muscle. If not, the bear could wake prematurely. 'We fly in quickly,' Dr Olberg said, and 'try to minimise the time we come in close to the bear... so we chase it as little as possible'. After a five- to 10-minute wait to make sure it is asleep, the team of scientists land and work quickly and precisely. They place a GPS collar around the bear's neck and replace the battery if the animal already has one. Only females are tracked with the collars because male polar bears – who can grow to 2.6m – have necks thicker than their heads, and would shake the collar straight off. Dr Olberg then made a precise cut in the bear's skin to insert a heart monitor between a layer of fat and the flesh. 'It allows us to record the bear's body temperature and heart rate all year,' NPI researcher Marie-Anne Blanchet told AFP, 'to see the energy the female bears (wearing the GPS) need to use up as their environment changes.' The first five were fitted last year, which means that for the first time experts can cross-reference their data to find out when and how far the bears have to walk and swim to reach their hunting grounds and how long they rest in their lairs. The vet also takes a biopsy of a sliver of fat that allows researchers to test how the animal might stand up to stress and 'forever chemicals', the main pollutants found in their bodies. 'The idea is to best represent what bears experience in the wild but in a laboratory,' said Belgian toxicologist Laura Pirard, who is testing the biopsy method on the mammals. Eating seaweed It has already shown that the diet of Svalbard's 300 or so bears is changing as the polar ice retreats. The first is that they are eating less seals and more food from the land, said Dr Jon Aars, the lead scientist of the NPI's polar bear programme. 'They still hunt seals, but they also take eggs and reindeer – they even eat (sea)grass and things like that, even though it provides them with no energy.' But seals remain their essential food source, he said. 'Even if they only have three months to hunt, they can obtain about 70 percent of what they need for the entire year during that period. That's probably why we see they are doing okay and are in good condition' despite the huge melting of the ice. But if warming reduces their seal hunting further, 'perhaps they will struggle', he warned. 'There are notable changes in their behaviour... but they are doing better than we feared. However, there is a limit, and the future may not be as bright.' 'The bears have another advantage,' said Ms Blanchet, 'they live for a long time, learning from experience all their life. That gives a certain capacity to adapt.' Success of anti-pollution laws Another encouraging discovery has been the tentative sign of a fall in pollution levels. With some 'bears that we have recaptured sometimes six or eight times over the years, we have observed a decrease in pollutant levels,' said Finnish ecotoxicologist Heli Routti, who has been working on the programme for 15 years. 'This reflects the success of regulations over the past decades.' NPI's experts contribute to the Arctic Monitoring and Assessment Programme (AMAP) whose conclusions play a role in framing regulations or bans on pollutants. 'The concentration of many pollutants that have been regulated decreased over the past 40 years in Arctic waters,' Dr Routti said. 'But the variety of pollutants has increased. We are now observing more types of chemical substances' in the bears' blood and fatty tissues. These nearly indestructible PFAS or 'forever chemicals' used in countless products like cosmetics and nonstick pans accumulate in the air, soil, water and food. Experts warn that they ultimately end up in the human body, particularly in the blood and tissues of the kidney or liver, raising concerns over toxic effects and links to cancer. AFP
Business Times
2 days ago
- Business Times
AstraZeneca vows to spend US$50 billion on US manufacturing, development
[MUNICH/WASHINGTON] AstraZeneca plans to invest US$50 billion in the US before 2030, becoming the latest European pharma company to ratchet up spending in the country ahead of potential tariffs on imported medicines. The investment will go towards manufacturing as well as research and development, Astra said in a statement. It includes US$4 billion for a new facility in Virginia that will make drugs for chronic diseases, Kevin Hassett, director of the US National Economic Council, said on Monday (Jul 21) at an event in Washington, DC. 'With the completion of this investment, substantially all of AstraZeneca's pharmaceuticals sold at the United States will be produced in the United States,' Hassett said. Astra's announcement comes as European drug companies rush to highlight their significant footprints in the US in hopes of mitigating the impact of any potential tariffs from US President Donald Trump. Astra already announced plans in November, a week after Trump's election, to invest US$3.5 billion in the US by the end of 2026, noting at the time that it employs nearly 18,000 people in the country. Since then, European competitors have touted even larger spending plans. Switzerland's Novartis in April announced plans for US$23 billion in US-based infrastructure spending, while cross-town rival Roche Holding said it would invest US$50 billion. In May, French drugmaker Sanofi announced intent to invest at least US$20 billion in the US by 2030. Pascal Soriot, who's been chief executive officer of Astra since 2012, has also urged tariff restraint. This spring, he recommended that US officials exempt medicines from tariffs, arguing that tax incentives are a better way to attract investment in drug development and manufacturing. BT in your inbox Start and end each day with the latest news stories and analyses delivered straight to your inbox. Sign Up Sign Up Trump has proposed various timelines for tariffs on pharmaceuticals, most recently floating duties that would be imposed as soon as Aug 1. The president said that he expects to give companies a year to bring manufacturing to the US before imposing tariffs as high as 200 per cent. Meanwhile, Soriot has raised concerns in the UK about his commitment to the home country. He has long complained about the UK's regulatory environment, which he says is a threat to hold back the UK from staying competitive with the US and China. In January, Astra abandoned plans for a £450 million (S$777 million) vaccine manufacturing plant in Liverpool. The company operates 17 manufacturing sites in 12 US states. Earlier this month, British paper The Times reported that Soriot is considering moving the company's stock listing to the US. That would be a major blow to the UK's equity markets, which have endured similar defections from other companies in recent years. Under Soriot's leadership, Astra's market value has more than tripled as the company has become a global powerhouse in cancer medicines. It's also built up a significant drug pipeline for other areas including cardiovascular, renal and metabolic diseases. BLOOMBERG